投資先としてのベルギー:ライフサイエンス分野 The case of Eurogentec S.A., investment in Life Sciences sector Hitoshi YAHARA Officer General Manager QOL Division 矢原 均 理事 QOL事業部長 株式会社カネカ 12 May, 2015 Belgium–Japan Joint Seminar Corporate Profile Name KANEKA CORPORATION President Mamoru Kadokura Date of establishment September 1, 1949 Financial Structure (as of March 31,2014) Paid-in Capital 33,046 million yen * Net Sales 524,785 million yen * Number of employees 8,907 * (consolidated basis) Head Office Osaka, Tokyo * (as of March 31,2014) 2 Activities in Life Science Field Expand business fields with many subsidiaries. Regenerative Medicine - Bio Master Bone Marrow MSC Separation Device Programmable Closed Circuit Cell Culture system Fat Stem Cell Therapy - Medical Devices Functional Foods - - Coenzyme Q10 Reduced Coenzyme Q10 Others - Plasmapheresis Treatment System Selective adsorption column PTCA Catheter Bio-Pharma related business Fine Chemicals DDS (Patient Friendly Drug) - - RSMs GMP Intermediates Transdermal Products Unique Oral Dosage Form KM Transderm APIs - CMO Services - Generic APIs Mab discovery support Protein A resin IVD Products cGMP BioManufacturing Genomics and Proteomics Eurogentec Anaspec Gene Frontier OSCL 3 Kaneka’s History in Belgium 4 Eurogentec Located in the Heart of Europe Eurogentec S.A. • 4 manufacturing sites – 2 in Belgium – 2 in California, USA – GMP Biologics facility in Belgium • Employees: 325 • Manufacturing – Custom research reagents – IVD oligonucleotides – GMP Biopharmaceuticals 5 Eurogentec Business Development and Contract Manufacturing of Innovative solutions for Life Science research Reliable components for Diagnostic field Biologics for Therapeutic applications Life Science Research Diagnostic Services GMP BioManufacturing Products and Services Manufacturing Solutions Proteins, Plasmids, Vaccines Solution Provider for Life Science Research & Biotech Companies cGMP Compliant Manufacturer for Clinical and Commercial Phases 6 Two Manufacturing Business Units Genomics Proteomics 10 500 m² of labs and offices in LIEGE SCIENCE Park (Belgium) and FREMONT (USA) Life Science Research products and services Oligonucleotides PCR and qPCR Kits & Reagents Ultra Pure Taq Polymerases Fluorophores and Quenchers Assay Dispensing Services Antibodies Peptides Assay Kits Biologics Multipurpose cGMP facilities GMP Manufacturing for clinical stage and market Process Development, Validation and Transfer Clinical & Commercial Manufacturing Drug Substance/Product Release Diagnostics : manufacturing of key components cGMP Oligonucleotides cGMP Taq Polymerase Antibodies GMP 7 Eurogentec’s History 2013, 2014 FDA successful routine inspection 2011 EGT became a part of Kaneka Acquisition of AnaSpec Inc., CA 2010 2009 2008 2004 Creation of EGT North America FDA successful pre-approval for inspection for commercial manufacturing 2001 2000 ISO 13485 Certification of IVD GMP Oligonucleotides manufacturing in Liege (BE) Start of GMP manufacturing of IVD Oligonucleotides in Liège ISO 9001 Certification 1996 CMO for the biopharmaceutical sector 1995 Peptides Synthesis 1994 GMP Production Facility accredited by Belgian Health Authorities 1985 1987 Oligonucleotides Synthesis Foundation 8 Vision for the Future Aspiration is to become the world’s leading company in biomanufacturing business through collaboration between Eurogentec and Kaneka Kaneka’s Features Eurogentec’s Features High quality standards in products and services Long experience in biomanufacturing Longstanding customer relationship High quality facilities and equipments Innovative and experienced R&D Vision To become the world’s leading company in biomanufacturing business Sufficient financial resources Strong relationship with big Pharma Experiences in other life science business e.g., Medical device Broad business portfolio 9 What makes Wallonia industrial-academic innovation network successful is: The proximity (geography and mental) of the partners The capacity to go get the best know-how where it lies A very good academic system that nurture education level and an "industrial mind" A very good expertise in "innovation" process from research to "product/service" development and company creation and management Examples of collaboration between Eurogentec and University of Liege Biologics DNAVAC – a Biowin project RECOINS – a public private partnership project REWARD – a BEWARE fellowships academia project ROBOTEINE – an Equip2013 project MycAvert – a WB health project Life Science Products and Services Quantified peptides for MS detection Universal standard for protein identification and quantification Beta-cells in vivo detection Optimization of Eurogentec’s products 10 ご静聴ありがとうございました。 Thank you for your attention. 11
© Copyright 2024